Filing Details
- Accession Number:
- 0001445064-15-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-19 17:25:39
- Reporting Period:
- 2015-05-18
- Filing Date:
- 2015-05-19
- Accepted Time:
- 2015-05-19 17:25:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1567892 | Mallinckrodt Plc | MNK | Pharmaceutical Preparations (2834) | 981088325 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1589593 | D. Mario Saltarelli | 675 Mcdonnell Blvd. Hazelwood MO 63042 | Sr. Vp & Chief Science Ofcr. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2015-05-18 | 3,912 | $0.00 | 11,388 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2015-05-18 | 4,580 | $127.44 | 6,808 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Ordinary Shares | Disposition | 2015-05-18 | 3,912 | $0.00 | 3,912 | $51.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,738 | 2015-01-02 | 2024-01-02 | No | 4 | M | Direct |
Footnotes
- This price represents a weighted average. The shares were sold at prices ranging from $127.43 to $127.46, inclusive. Mr. Saltarelli will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in this Form 4.